High Vista Strategies LLC Acelrx Pharmaceuticals Inc Transaction History

High Vista Strategies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.76 - $2.07 $31,464 - $85,698	-41,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.66 - $2.4 $31,042 - $44,880	18,700 Added 82.38%	41,400 $87,000
Q3 2019 Nov 14, 2019	BUY	$2.1 - $2.87 $47,670 - $65,149	22,700 New	22,700 $50,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.